Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, and Leukocare AG, a German biotechnology company specialized in formulation development, expanded their alliance into the U.S. with the recent opening of Leukocare’s U.S. development labs and offices at Rentschler’s facility in the Greater Boston area, where the two companies will work together.   This alliance integrates tailored formulation development expertise into each step of the manufacturing process to help address th...